StonvexLoading…
StonvexStonvexStonvexCore line items from GRND's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $439.90M | $344.64M | $259.69M | $195.01M |
Operating Income | $126.29M | $92.60M | $55.45M | $13.04M |
Net Income | $94.75M | $-131.00M | $-55.77M | $852.00K |
EPS (Diluted) | $0.43 | $-0.74 | $-0.32 | $0.01 |
Total Assets | $531.03M | $479.09M | $444.60M | $438.83M |
Total Liabilities | $484.02M | $610.66M | $462.89M | $434.78M |
Cash & Equivalents | $87.05M | $59.15M | $27.61M | $8.72M |
Free Cash Flow OCF − CapEx | $140.77M | $94.01M | $35.64M | $50.21M |
Shares Outstanding | 185.03M | 177.19M | 175.02M | 173.52M |